📰 Andreaf Wainer News
Page 44 - Andreaf Wainer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Andreaf Wainer. Real-time updates on events, politics, business and more.
January 4, 2024
Patton Albertson Miller Group LLC grew its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 12.9% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 12,119 shares of the healthcare product maker’s stock after buying an additional 1,381 shares during the period. Patton Albertson […]
January 4, 2024
Bank of New York Mellon Corp reduced its position in Abbott Laboratories (NYSE:ABT – Free Report) by 3.8% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 14,603,003 shares of the healthcare product maker’s stock after selling 569,235 shares during the period. Bank of New York Mellon Corp […]
January 4, 2024
Guyasuta Investment Advisors Inc. trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.4% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 24,025 shares of the healthcare product maker’s stock after selling 106 shares during the quarter. Guyasuta Investment Advisors Inc.’s holdings […]
January 4, 2024
BLB&B Advisors LLC lessened its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 1.2% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 38,553 shares of the healthcare product maker’s stock after selling 455 shares during the quarter. BLB&B Advisors LLC’s holdings […]
January 4, 2024
Genesee Capital Advisors LLC lowered its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 3.8% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 13,977 shares of the healthcare product maker’s stock after selling 553 shares during the period. Genesee Capital […]
January 4, 2024
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
January 4, 2024
Bridges Investment Management Inc. trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 81,462 shares of the healthcare product maker’s stock after selling 339 shares during the period. Bridges Investment Management Inc.’s […]
January 3, 2024
Abbott Laboratories (NYSE:ABT – Get Free Report) had its price target upped by equities research analysts at Raymond James from $110.00 to $124.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage presently has an “outperform” rating on the healthcare product maker’s stock. Raymond James’ target price would suggest a potential […]
January 3, 2024
Prentiss Smith & Co. Inc. increased its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.5% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 41,801 shares of the healthcare product maker’s stock after buying an additional 607 shares during the period. Abbott Laboratories accounts for about 3.0% of Prentiss Smith & […]
January 3, 2024
Prentiss Smith & Co. Inc. raised its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 41,801 shares of the healthcare product maker’s stock after purchasing an additional 607 shares during the […]